VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,010,017 | -35.5% | 1,369,623 | 0.0% | 2.53% | -45.0% |
Q2 2023 | $32,583,331 | -6.5% | 1,369,623 | 0.0% | 4.59% | -23.3% |
Q1 2023 | $34,843,209 | -12.9% | 1,369,623 | 0.0% | 5.99% | -5.6% |
Q4 2022 | $40,006,688 | +42.4% | 1,369,623 | 0.0% | 6.35% | +28.5% |
Q3 2022 | $28,091,000 | +157.2% | 1,369,623 | +45.1% | 4.94% | +97.5% |
Q2 2022 | $10,923,000 | -37.4% | 944,092 | 0.0% | 2.50% | -39.4% |
Q1 2022 | $17,456,000 | -6.5% | 944,092 | 0.0% | 4.13% | -32.9% |
Q4 2021 | $18,665,000 | +20.2% | 944,092 | 0.0% | 6.15% | +9.0% |
Q3 2021 | $15,530,000 | +2319.0% | 944,092 | +2590.3% | 5.65% | +2039.0% |
Q2 2021 | $642,000 | +10.5% | 35,092 | 0.0% | 0.26% | +7.8% |
Q1 2021 | $581,000 | – | 35,092 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |